Stroke-inducing clots efficiently dissolved by heart attack drug: Canadian researchers
A drug used to treat heart attacks has proven to be an effective treatment for the most common type of stroke, and an even better treatment than the current clinical standard, says a team of Canadian researchers.
Over 80 per cent of all strokes are ischemic strokes, caused by a blood clot blocking, or narrowing, an artery leading to the brain. For over 20 years, the standard of care has been the immediate delivery of a clot-busting medication called Alteplase (tPA).
In the largest study of its kind ever run in Canada, researchers at the University of Calgary and University of Toronto found that the drug Tenecteplase (TNK), currently used in heart attack treatment, is at least equally effective as tPA and possibly more effective in treating ischemic strokes.
"Tenecteplase is known to be an effective clot dissolving drug," explained U of C researcher Dr. Bijoy Menon. "It is very easy to administer which makes it a game changer when seconds count to save brain cells."
The Alteplase Compared to Tenecteplase study found Tenecteplase (TNK), a heart attack treatment drug, to be a much more favourable treatment for ischemic strokes than tPA as it's easier to administer.
Menon says the findings of the AcT (Alteplase Compared to Tenecteplase) trial were so conclusive he expects TNK to become the standard of care worldwide in very short order.
"Guideline Committees get the results, they debate the results, and then the transition happens. So I see this move happening within the next few months," said Menon.
"The results are very convincing. It's quite clear at the end of the study that you now have a better choice, and because of the debilitating nature of stroke, there's urgency to actually change care."
The current standard of care, tPAm, is complex to administer. It takes up to an hour and requires an infusion pump that needs to be monitored. The pump makes it more difficult to transport patients within a hospital or by ambulance to a larger facility with a dedicated stroke center for treatment.
By comparison, TNK is administered with a single dose through a syringe. The method eases the burden on nurses and doctors, and shaves time off the delivery of the medicine. U of T researcher Dr. Rick Swartz says it also means it will be available as a treatment in more places.
"TNK could potentially be administered wherever the patient is seen first, at a medical centre or small hospital," explained Swartz. "One of the reasons Tenecteplase is so effective is that in can be administered as a single immediate dose. That's a big advantage, saving critical time and complication."
TNK attaches itself to the clot for a longer period of time than tPA, meaning blood flow is restored faster and for a longer period of time. Project nurse lead Carol Kenney says it will save lives.
"In our field we say 'time is brain' and any minute or any second that we can save in treating a patient is critical," said Kenney. "Giving them medication quicker, and trying to get rid of the clot in their brain and get them back to normal again quickly, is so important. It really matters for every patient."
Stroke survivor André Lavoie, who suffered a stroke in 2015, was part of a focus group that helped guide researchers. While he has recovered from the stroke, Lavoie remains acutely aware of the need for effective, immediate treatment.
"It is really an advancement to get the people to survive, and the whole thing with a stroke is; you may survive a stroke, but it's your quality of life that you will looking for," said Lavoie
"So if you have a stroke, and you can have that drug within half an hour an hour, it's much better than two hours, or three hours to get it. Brain cells usually do not regenerate. So when they die, they die."
The cross-country AcT Trial included 1600 patients in 22 primary and comprehensive stroke centers across Canada. The results were presented at a conference in Montreal on Wednesday, and published in the medical journal The Lancet.
CTVNews.ca Top Stories
BREAKING Israel attacks Iran, Reuters sources say; drones reported over Isfahan
Israel has attacked Iran, three people familiar with the matter told Reuters, as Iranian state media reported early on Friday that its forces had destroyed drones, days after Iran launched a retaliatory drone strike on Israel.
American millionaire Jonathan Lehrer denied bail after being charged with killing Canadian couple
American millionaire Jonathan Lehrer, one of two men charged in the killings of a Canadian couple in Dominica, has been denied bail.
Nearly half of China's major cities are sinking, researchers say
Nearly half of China's major cities are suffering 'moderate to severe' levels of subsidence, putting millions at risk of flooding especially as sea levels rise.
Prince Harry formally confirms he is now a U.S. resident
Prince Harry, the son of King Charles III and fifth in line to the British throne, has formally confirmed he is now a U.S. resident.
Judge says 'no evidence fully supports' murder case against Umar Zameer as jury starts deliberations
The judge presiding over the trial of a man accused of fatally running over a Toronto police officer is telling jurors the possible verdicts they may reach based on the evidence in the case.
Health Canada to change sperm donor screening rules for men who have sex with men
Health Canada will change its longstanding policy restricting gay and bisexual men from donating to sperm banks in Canada, CTV News has learned. The federal health agency has adopted a revised directive removing the ban on gay, bisexual and other men who have sex with men, effective May 8.
Colin Jost names one celebrity who is great at hosting 'Saturday Night Live'
Colin Jost, who co-anchors Saturday Night Live's 'Weekend Update,' revealed who he thinks is one of the best hosts on the show.
Sports columnist apologizes for 'oafish' comments directed at Caitlin Clark. The controversy isn't over
A male columnist has apologized for a cringeworthy moment during former University of Iowa superstar and college basketball's highest scorer Caitlin Clark's first news conference as an Indiana Fever player.
'Shopaholic' author Sophie Kinsella reveals brain cancer diagnosis
Sophie Kinsella, the best-selling author behind the 'Shopaholic' book series, has revealed that she is receiving treatment for brain cancer.